308 related articles for article (PubMed ID: 28947337)
1. Synthesis, Characterization, and Crystal Chemistry of Tasimelteon, a Melatonin Agonist, in Its Anhydrous and Hemihydrate Forms.
Ventimiglia G; Bellomi S; Barreca G; Giovannelli L; Masciocchi N
J Pharm Sci; 2018 Feb; 107(2):543-549. PubMed ID: 28947337
[TBL] [Abstract][Full Text] [Related]
2. Anhydrates and hemihydrate of tasimelteon: Synthesis, structure, and pharmacokinetic study.
Liu K; Zhou X; Xu Z; Bai H; Zhu J; Gu J; Tang G; Liu X; Hu X
J Pharm Biomed Anal; 2018 Mar; 151():235-243. PubMed ID: 29413972
[TBL] [Abstract][Full Text] [Related]
3. Crystal chemistry of the antibiotic doripenem.
Colombo V; Masciocchi N; Palmisano G
J Pharm Sci; 2014 Nov; 103(11):3641-3647. PubMed ID: 25231384
[TBL] [Abstract][Full Text] [Related]
4. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
Malpezzi L; Magnone GA; Masciocchi N; Sironi A
J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
[TBL] [Abstract][Full Text] [Related]
5. Small molecule, big difference: the role of water in the crystallization of paclitaxel.
Vella-Zarb L; Baisch U; Dinnebier RE
J Pharm Sci; 2013 Feb; 102(2):674-83. PubMed ID: 23203212
[TBL] [Abstract][Full Text] [Related]
6. Lisinopril dihydrate: single-crystal x-ray structure and physicochemical characterization of derived solid forms.
Sorrenti M; Catenacci L; Cruickshank DL; Caira MR
J Pharm Sci; 2013 Oct; 102(10):3596-603. PubMed ID: 23873413
[TBL] [Abstract][Full Text] [Related]
7. Characterization and crystal structure of D-mannitol hemihydrate.
Nunes C; Suryanarayanan R; Botez CE; Stephens PW
J Pharm Sci; 2004 Nov; 93(11):2800-9. PubMed ID: 15368529
[TBL] [Abstract][Full Text] [Related]
8. Rufinamide: Crystal structure elucidation and solid state characterization.
Salunke N; Thipparaboina R; Chavan RB; Lodagekar A; Mittapalli S; Nangia A; Shastri NR
J Pharm Biomed Anal; 2018 Feb; 149():185-192. PubMed ID: 29121573
[TBL] [Abstract][Full Text] [Related]
9. A new polymorph of ciprofloxacin saccharinate: Structural characterization and pharmaceutical profile.
Singh P; Chadha R
J Pharm Biomed Anal; 2017 Nov; 146():7-14. PubMed ID: 28841428
[TBL] [Abstract][Full Text] [Related]
10. The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market.
Sieger P; Werthmann U; Saouane S
Eur J Pharm Sci; 2023 Jul; 186():106447. PubMed ID: 37044200
[TBL] [Abstract][Full Text] [Related]
11. Tasimelteon: a selective and unique receptor binding profile.
Lavedan C; Forsberg M; Gentile AJ
Neuropharmacology; 2015 Apr; 91():142-7. PubMed ID: 25534555
[TBL] [Abstract][Full Text] [Related]
12. Solid-state characterization and transformation of various creatine phosphate sodium hydrates.
Xu Y; Jiang L; Huang Y; Wang JR; Mei X
J Pharm Sci; 2014 Nov; 103(11):3688-3695. PubMed ID: 25223726
[TBL] [Abstract][Full Text] [Related]
13. Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphs.
Maccaroni E; Malpezzi L; Panzeri W; Masciocchi N
J Pharm Biomed Anal; 2010 Sep; 53(1):1-6. PubMed ID: 20347245
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of Alprazolam (Xanax): a review of its crystalline phases and identification, crystallographic characterization, and crystal structure of a new polymorph (form III).
de Armas HN; Peeters OM; Van den Mooter G; Blaton N
J Pharm Sci; 2007 May; 96(5):1114-30. PubMed ID: 17455340
[TBL] [Abstract][Full Text] [Related]
15. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
Nishimon S; Nishimon M; Nishino S
Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759
[TBL] [Abstract][Full Text] [Related]
16. Novel polymorph of ambrisentan: Characterization and stability.
Haneef J; Chadha R; Gupta V; Mandal SK
J Pharm Biomed Anal; 2018 May; 153():102-109. PubMed ID: 29475138
[TBL] [Abstract][Full Text] [Related]
17. New solid modifications of nateglinide.
Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Lanfranconi S; Marini A
J Pharm Biomed Anal; 2010 Apr; 51(5):1054-9. PubMed ID: 20022441
[TBL] [Abstract][Full Text] [Related]
18. Tasimelteon (Hetlioz™): A New Melatonin Receptor Agonist for the Treatment of Non-24-Hour Sleep-Wake Disorder.
Bonacci JM; Venci JV; Gandhi MA
J Pharm Pract; 2015 Oct; 28(5):473-8. PubMed ID: 25092604
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine: Design and synthesis of new multicomponent solid forms.
Évora AOL; Castro RAE; Maria TMR; Ramos Silva M; Canotilho J; Eusébio MES
Eur J Pharm Sci; 2019 Mar; 129():148-162. PubMed ID: 30639400
[TBL] [Abstract][Full Text] [Related]
20. Understanding the dehydration of levofloxacin hemihydrate.
Gorman EM; Samas B; Munson EJ
J Pharm Sci; 2012 Sep; 101(9):3319-30. PubMed ID: 22610517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
